As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards.
Part 4 of 4.Â
Part 4 of 4.Â
My guest for this week’s episode is Nathan Clark, Founder and CEO of Ganymede. Ganymede is the modern cloud data platform for the life sciences and manufacturing. Their Lab-as-Code technology allows you to quickly integrate and harmonize lab instruments and app data, automate analysis, visualize all your data in dashboards built over a powerful data lake, and ultimately speed up your operations to accelerate science or production.
Prior to founding Ganymede, Nathan was Product Manager for several of Benchling's data products, including the Insights BI tool and Machine Learning team. Before Benchling, Nathan worked at Affirm as a Senior Product Manager and was also a Trader at Goldman Sachs.
Join us this week and hear about:
- Nathan’s experience with data integration and automation in the life sciences and building a product for bioinformatics engineers and data scientistsÂ
- His experience building the technical team and creating a go-to-market motion
- His vision for Ganymede in the years to come
- The challenges biotech companies face managing and analyzing large amounts of dataÂ
- The importance of streamlining processes through automation and data integration
Nathan’s extensive background in machine learning and data systems across financial and lab technology and knowledge of their applications in the life sciences offers unique insights for founders to benefit from. Please enjoy my conversation with Nathan Clark.
Timestamps:
00:28 Intro
01:56 Empowering bioinformatics engineers with data integration and automationÂ
04:38 The vision for Ganymede’s developer platform; automating wet lab dataÂ
06:39 The key to Ganymede’s quick growth: faster integrationsÂ
08:18 Nathan’s go-to-market motion at Ganymede; explaining your productÂ
10:29 Which companies benefit the most from Ganymede?Â
14:23 Data strategies, modern data stacks, and building a data lakeÂ
20:21 Future vision for Ganymede; expanding platform features and reducing bugging cycles 27:02 Automating complex workflows to unlock the next level of R&DÂ
29:40 Shout-outs and advice for 21-year old selfÂ
33:29 Outro
Find Our Guest, Nathan Clark, at these links:Â
Find Our Host, Jon Chee, at these links:Â
Social & Website
LinkedIn: https://www.linkedin.com/company/excedr/Â
Youtube: https://www.youtube.com/@excedrÂ
Instagram: https://www.instagram.com/excedr_incÂ
Twitter: https://twitter.com/ExcedrIncÂ
Facebook: https://www.facebook.com/excedrÂ
TikTok: https://www.tiktok.com/@excedrÂ
Podcast Website: https://www.thebiotechstartupspodcast.com/Â
Enriched Notes:
Topics Mentioned:
Ganymede https://www.ganymede.bio/
Ganymede Products https://www.ganymede.bio/products
Salesforce https://www.salesforce.com/
Hubspot https://www.hubspot.com/
Ramp https://ramp.com/
Benchling https://www.benchling.com/
Data Science & Analysis https://aws.amazon.com/what-is/data-science/
Bioinformatics https://www.genome.gov/genetics-glossary/Bioinformatics
Automating Wet Lab Data https://blog.ganymede.bio/4-data-first-strategies-for-lab-automation/
Data Lakes & the Modern Data Stack https://blog.ganymede.bio/the-essential-lab-data-tech-stack-for-every-stage-of-drug-development/
People Mentioned:
Nicholas (Nicky) Ksiezopolski https://www.linkedin.com/in/nksiezopolski/
Sanjay Saraf https://www.linkedin.com/in/sanjaysaraf/
The Biotech Startups Podcast gives you a front-row seat to the business and science of building a biotech. Hosted by Jon Chee, CEO of Excedr, the show features honest conversations with founders, execs, and investors about their work, their companies, and how they got there. From scientific breakthroughs to startup lessons, each episode explores what it really takes to grow a life science company—from pre-seed to IPO.
Fler avsnitt av The Biotech Startups Podcast
Visa alla avsnitt av The Biotech Startups PodcastThe Biotech Startups Podcast med Excedr finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
